piritrexim has been researched along with Brain Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baccanari, DP; Boytos, CM; Caddell, JM; Comley, JC; Friedman, HS; Hunter, RN; Jones, ML; Joyner, SS; Knick, V; Kuyper, LF; Rudolph, SK; Stables, JN; Tansik, RL; Wilson, HR | 1 |
| Bedford, P; Bleehen, NM; Nethersell, AB; Newman, HV; Rampling, RP; Ramsay, JR; Roberts, JT | 1 |
| Adamson, PC; Arndt, C; Aronson, L; Balis, FM; Clendeninn, NJ; Gillespie, A; Miser, J; Penta, JS; Poplack, DG; Wells, RJ | 1 |
2 trial(s) available for piritrexim and Brain Neoplasms
| Article | Year |
|---|---|
A phase II study of oral piritrexim in recurrent high-grade (III, IV) glioma.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Drug Administration Schedule; Female; Folic Acid Antagonists; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Pyrimidines | 1995 |
Pediatric phase I trial, pharmacokinetic study, and limited sampling strategy for piritrexim administered on a low-dose, intermittent schedule.
Topics: Adolescent; Adult; Antineoplastic Agents; Brain Neoplasms; Child; Child, Preschool; Drug Administration Schedule; Drug Evaluation; Female; Glioma; Humans; Leukocyte Count; Male; Neoplasms; Platelet Count; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Sarcoma | 1992 |
1 other study(ies) available for piritrexim and Brain Neoplasms
| Article | Year |
|---|---|
High-affinity inhibitors of dihydrofolate reductase: antimicrobial and anticancer activities of 7,8-dialkyl-1,3-diaminopyrrolo[3,2-f]quinazolines with small molecular size.
Topics: Animals; Anti-Infective Agents; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Brain Neoplasms; Candidiasis; Cell Division; Cell Line; Crystallography, X-Ray; Drug Design; Drug Resistance, Multiple; Enzyme Inhibitors; Folic Acid Antagonists; Humans; Lung Neoplasms; Magnetic Resonance Spectroscopy; Mass Spectrometry; Mice; Mice, Nude; Mice, SCID; Models, Molecular; Molecular Conformation; Molecular Structure; Molecular Weight; Pneumonia, Pneumocystis; Protein Structure, Secondary; Quinazolines; Structure-Activity Relationship; Toxoplasma; Tumor Cells, Cultured | 1996 |